Paper216819
Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy.
Hochberg FH and 4 others. JAMA, 1979. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy. Papers, record 216819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/216819
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Lomustine | Major topic |
| Nitrosourea Compounds | Major topic |
| Activities of Daily Living | |
| Adult | |
| Aged | |
| Drug Tolerance | |
| Humans | |
| Middle Aged | |
| Postoperative Care | |
| Prognosis | |
| Quality of Life | |
| Time Factors |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42639298 | Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42639298 | PubMed |
| 41501375 | The functional imperative in high-grade glioma. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/41501375 | PubMed |
| 41208963 | Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41208963 | PubMed |
| 39445563 | Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies. | Ther Deliv | 2025 | https://conductscience.org/library/papers/39445563 | PubMed |
| 38578405 | Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma. | Curr Neurol Neurosci Rep | 2024 | https://conductscience.org/library/papers/38578405 | PubMed |
| 38258110 | Targeted Glioma Therapy-Clinical Trials and Future Directions. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38258110 | PubMed |
| 37894287 | Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894287 | PubMed |
| 37686584 | The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686584 | PubMed |
| 37686553 | Recurrent Glioblastoma: A Review of the Treatment Options. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686553 | PubMed |
| 37371674 | Personalized Treatment of Glioblastoma: Current State and Future Perspective. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371674 | PubMed |
| 36673007 | Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36673007 | PubMed |
| 35849181 | Effectiveness of mindfulness-based supportive psychotherapy on posttraumatic growth, resilience, and self-compassion in cancer patients : A pilot study. | Wien Klin Wochenschr | 2022 | https://conductscience.org/library/papers/35849181 | PubMed |
| 35047971 | Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting? | Front Med Technol | 2021 | https://conductscience.org/library/papers/35047971 | PubMed |
| 33810154 | Current FDA-Approved Therapies for High-Grade Malignant Gliomas. | Biomedicines | 2021 | https://conductscience.org/library/papers/33810154 | PubMed |
| 29123345 | Effect of Supportive Psychotherapy on Mental Health Status and Quality of Life of Female Cancer Patients Receiving Chemotherapy for Recurrent Disease. | Indian J Palliat Care | 2017 | https://conductscience.org/library/papers/29123345 | PubMed |
| 25821160 | Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution. | Oncotarget | 2015 | https://conductscience.org/library/papers/25821160 | PubMed |
| 24590402 | Quality of life and brain tumors: what beyond the clinical burden? | J Neurol | 2014 | https://conductscience.org/library/papers/24590402 | PubMed |
| 17164049 | Net clinical benefit: functional endpoints in brain tumor clinical trials. | Curr Oncol Rep | 2007 | https://conductscience.org/library/papers/17164049 | PubMed |
| 12622451 | Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12622451 | PubMed |
| 8865005 | Quality of life in brain tumor patients. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8865005 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/216819
GET https://conductscience.org/api/papers/v1/216819/cited_by?page=2